In addition, treatment with 20 ng/mL FGF7 alone was sufficient to increase the cell proliferation, and cell invasion of OSRC-2 and A498 cells (Figure 2G–I), suggesting that the induced FGF7 expression is a prerequisite for CAFs to promote ccRCC progression. The gene discussed is FGF7; the disease is nonpapillary renal cell carcinoma.